Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-094048
Filing Date
2024-08-28
Accepted
2024-08-28 17:01:02
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2421399d1_s3.htm S-3 412665
2 EXHIBIT 4.2 tm2421399d1_ex4-2.htm EX-4.2 383528
3 EXHIBIT 4.3 tm2421399d1_ex4-3.htm EX-4.3 373290
4 EXHIBIT 5.1 tm2421399d1_ex5-1.htm EX-5.1 16467
5 EXHIBIT 5.2 tm2421399d1_ex5-2.htm EX-5.2 8984
6 EXHIBIT 23.1 tm2421399d1_ex23-1.htm EX-23.1 3143
7 EX-FILING FEES tm2421399d1_ex-filingfees.htm EX-FILING FEES 65770
8 GRAPHIC tm2421399d1_ex23-1img001.jpg GRAPHIC 18588
9 GRAPHIC tm2421399d1_ex5-1img001.jpg GRAPHIC 2612
10 GRAPHIC tm2421399d1_s3img001.jpg GRAPHIC 6460
11 GRAPHIC tm2421399d1_s3img002.jpg GRAPHIC 5005
  Complete submission text file 0001104659-24-094048.txt   1310879
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

EIN.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281827 | Film No.: 241256484
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)